IL6 and rheumatoid arthritis: While TNFi and other DMARDs such as interleukin-6 (IL-6) inhibitors and Janus kinase inhibitors can be quite effective at treating RA, a large fraction of patients still does not reach a major clinical response with current therapies (4).